Beck J D, Gromball J, Klingenbiel T, Ritter J, Henze G, Riehm H, Hiddermann W
Haematol Blood Transfus. 1987;30:509-12. doi: 10.1007/978-3-642-71213-5_89.
An aneuploid DNA stem line has been detected by flow cytometric measurements in 17 (29%) out of 59 children entered in the BFM 83 pilot study for ALL relapse. Of 17 DNA aneuploidies, 15 were hyperdiploid. Euploidy was observed in 28 of 34 patients with an early relapse, whereas 11 of 25 children suffering a late recurrence of disease showed aneuploid DNA stem lines. In contradistinction to ALL relapse, a significantly higher frequency (38%) of pretreatment DNA aneuploidy was measured in 376 newly diagnosed patients of the BFM trials. Our findings may reflect the impact of therapy on leukemic cell clones and their relapse pattern.
在参加BFM 83 ALL复发试验性研究的59名儿童中,通过流式细胞术检测发现,17名(29%)存在非整倍体DNA干细胞系。在这17例DNA非整倍体中,15例为超二倍体。34例早期复发患者中有28例观察到整倍体,而25例疾病晚期复发的儿童中有11例显示非整倍体DNA干细胞系。与ALL复发情况相反,在BFM试验的376例新诊断患者中,预处理时DNA非整倍体的频率显著更高(38%)。我们的研究结果可能反映了治疗对白血病细胞克隆及其复发模式的影响。